Company news
Cisen Pharmaceutical Ltd. Class A (SSE:603367) news
Cisen Pharmaceutical Ltd. Class A news releases on 6ix. Latest, Sep 23, 2026: "Cisen Pharmaceutical Co., Ltd."Announcement on Resolutions of the 1st…
Press releases & updates
"Cisen Pharmaceutical Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 22, 2026
"Cisen Pharmaceutical Co., Ltd."Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops
September 14, 2026
"Cisen Pharmaceutical Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
September 7, 2026
"Cisen Pharmaceutical Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance and Cash Dividend Briefing
September 2, 2026
"Cisen Pharmaceutical Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
August 24, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 27, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 12, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 7, 2026
Report for Q1 2026
April 28, 2026
Announcement on Completion of Shareholding Reduction Plan for Shareholders and Results of Shareholding Reduction
April 15, 2026
Announcement on Outline of the 2025 Annual Performance and Cash Dividend Briefing
April 13, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 2, 2026
Announcement on Shareholding Reduction Plan for Shareholders
March 13, 2026
Announcement on Changing Sponsor Representative
February 10, 2026
Announcement on Release of Pledge of Shareholder's Shares
January 8, 2026
Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management and Securities Investment by the Company and its Holding Subsidiary
January 5, 2026
Announcement on Outline of the Q3 2025 Performance Briefing
November 26, 2025
Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares and Person Acting in Concert Reaching 1% Scale
November 25, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 20, 2025
Announcement on Changing Name, Registered Address and Business Scope of Person Acting in Concert of Shareholders with More than 5% of the Shares
November 17, 2025
Announcement on By-election of Members of the Remuneration and Evaluation Committee of the 5th Board of Directors
October 28, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
September 26, 2025
Announcement on Completion of Shareholding Reduction Plan for Shareholders with Over 5% Shares and Results of Shareholding Reduction
September 24, 2025
Announcement on Resignation of Director and Election of Employee Representative Director
September 23, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 16, 2025
Announcement on Outline of the 2025 Semi-annual Performance and Cash Dividend Briefing
September 2, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
August 31, 2025
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
August 29, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 27, 2025
Announcement on Risk Warning in Stock Trading
July 30, 2025
Announcement on Abnormal Fluctuations in Stock Trading
July 29, 2025
Announcement on Release of Pledge of Some Shares Held by Shareholders with Over 5% Shares
July 1, 2025
Announcement on Release of Pledge and Re-pledge of Partial Shares Held by Shareholder with Over 5% Shares
June 25, 2025
Announcement on Pledge of Some Shares by Shareholders Holding More Than 5% of Shares
June 18, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 12, 2025
Announcement on Expiration of Share Reduction Plan for Shareholders with Over 5% Shares and Results of Share Reduction
June 4, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 20, 2025
Announcement on Attending the 2025 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
May 12, 2025
Announcement on Progress in Using Idle Raised Funds for Cash Management
May 9, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
April 28, 2025
2024 Annual Report
April 21, 2025
Announcement on Resolutions of the 7th Meeting of the 5th Board of Directors
April 1, 2025
Announcement on Release of Pledge of Some Shares of Controlling Shareholder
February 26, 2025
Announcement on Share Reduction Plan for Shareholders Holding Over 5% of Shares
February 7, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
January 24, 2025
Announcement on Providing Online Voting Prompt Services for the General Meeting
January 16, 2025
Announcement on Resolution of the 6th Meeting of the 5th Board of Supervisors
January 7, 2025
Announcement on the Change of Registered Capital and Completion of Industrial and Commercial Registration Changes
December 26, 2024
Announcement on Pledge of Shares by the Controlling Shareholder
December 12, 2024
Announcement on Release of Controlling Shareholders' Share Pledge
November 29, 2024